Sale!

Epstein-Barr Virus Antibody to Early Antigen D IgG Test

Original price was: $450.Current price is: $326.

-28%

The Epstein-Barr Virus Antibody to Early Antigen D IgG Test is a specialized diagnostic tool that detects IgG antibodies against the early antigen D component of the Epstein-Barr virus. This test helps identify current or recent EBV infections, monitor chronic EBV conditions, and assess immune response to the virus. It’s particularly valuable for patients experiencing persistent fatigue, mononucleosis symptoms, or suspected chronic EBV infections. The test provides crucial information about viral activity and immune system response, helping healthcare providers make informed treatment decisions. Available for only $326 USD, this advanced testing option offers comprehensive EBV monitoring and diagnosis for better patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Epstein-Barr Virus Antibody to Early Antigen D IgG Test

Understanding Epstein-Barr Virus and Early Antigen D IgG Testing

The Epstein-Barr Virus (EBV) Antibody to Early Antigen D IgG Test represents a sophisticated diagnostic approach to detecting and monitoring EBV infections. Epstein-Barr virus is one of the most common human viruses, affecting over 90% of adults worldwide. This specific test targets the early antigen D component, which appears during the active replication phase of the virus, providing valuable insights into current or recent infection status.

What Does This Test Measure?

This specialized immunoassay detects IgG antibodies specifically directed against the early antigen D (EA-D) of the Epstein-Barr virus. Unlike other EBV antibodies that may persist for years, EA-D IgG antibodies typically indicate:

  • Active or recent EBV infection
  • Viral replication activity
  • Immune system response to current infection
  • Potential chronic EBV infection patterns

Who Should Consider This Test?

This test is particularly valuable for individuals experiencing symptoms that may indicate EBV infection or reactivation:

  • Patients with persistent fatigue lasting weeks or months
  • Individuals with mononucleosis-like symptoms (fever, sore throat, swollen lymph nodes)
  • Those with unexplained fever or chronic fatigue syndrome
  • Patients with suspected chronic active EBV infection
  • Immunocompromised individuals experiencing EBV-related complications
  • People with recurrent or persistent symptoms despite previous EBV infection

Clinical Indications and Symptoms

Healthcare providers often recommend this test when patients present with:

  • Prolonged fatigue that interferes with daily activities
  • Unexplained fever and night sweats
  • Swollen lymph nodes in neck and armpits
  • Sore throat and difficulty swallowing
  • Muscle aches and joint pain
  • Enlarged spleen or liver abnormalities

Benefits of Early Antigen D IgG Testing

Choosing this specific EBV antibody test offers several significant advantages:

  • Accurate Infection Timing: Helps distinguish between recent and past infections
  • Active Infection Detection: Identifies current viral replication activity
  • Treatment Monitoring: Tracks response to antiviral therapies
  • Chronic Condition Assessment: Evaluates potential chronic EBV infection
  • Comprehensive Diagnosis: Provides crucial information for differential diagnosis
  • Early Intervention: Enables timely treatment decisions

Understanding Your Test Results

Interpreting EBV Early Antigen D IgG results requires professional medical expertise, but here’s general guidance:

  • Positive Result: Indicates current or recent EBV infection with active viral replication
  • Negative Result: Suggests no recent active EBV infection, though past infection may still be present
  • Borderline Results: May require repeat testing or additional EBV antibody panels
  • Pattern Analysis: Results are often interpreted alongside other EBV antibody tests for comprehensive assessment

Test Pricing and Availability

Test Description Price (USD)
Epstein-Barr Virus Antibody to Early Antigen D IgG Test $450
Discount Price $326

Nationwide Testing Availability

We have comprehensive testing facilities across the United States, including major metropolitan areas:

  • New York City and surrounding areas
  • Los Angeles and Southern California
  • Chicago and Midwest regions
  • Houston and Texas locations
  • Phoenix and Arizona centers
  • Philadelphia and Northeast facilities
  • San Antonio and additional Texas sites
  • San Diego and California locations
  • Dallas and North Texas centers
  • San Jose and Bay Area facilities

Sample Requirements and Processing

For accurate testing, please note the following requirements:

  • Sample Type: 2 mL (1 mL minimum) serum from 1 SST
  • Shipping: Ship refrigerated or frozen
  • Mandatory Documentation: Duly filled Test Send Out Consent Form (Form 35)
  • Turnaround Time: Sample by 7th of the month; Report after 2-3 weeks

Why Choose Our EBV Testing Services?

Our laboratory maintains the highest standards in infectious disease testing:

  • Advanced immunoassay technology for precise results
  • Experienced infectious disease specialists
  • Comprehensive test interpretation support
  • Nationwide network of testing facilities
  • Competitive pricing with significant discounts
  • Professional medical guidance throughout the process

Take Control of Your Health Today

Don’t let unexplained symptoms persist. The Epstein-Barr Virus Antibody to Early Antigen D IgG Test provides crucial information for understanding your health status and guiding appropriate medical care. Our experienced team is ready to assist you with comprehensive testing and professional support.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your Epstein-Barr Virus Antibody to Early Antigen D IgG Test and take the first step toward better health understanding.